机器人辅助根治性前列腺切除术中海绵体神经术中监测与标测新方法的建立:I/II期首次人体可行性研究结果
本研究为前瞻性I/II期首次人体可行性研究,纳入30例在高容量三级学术医院接受机器人辅助根治性前列腺切除术的前列腺癌患者,评估术中海绵体神经监测与标测方案的安全性和临床可行性。主要终点为计划手术和评估的完成率,结果为100%;仅1例患者出现与研究干预无关的不良事件。海绵体海绵体肌电图分级与基线IIEF-5评分、术后勃起功能恢复及术后IIEF-5评分显著相关。
要点
- 术中海绵体肌电图监测与标测方案完成率达100%,仅1例发生与研究干预无关的不良事件。
- 前列腺切除前神经血管束触发的海绵体肌电图分级与基线IIEF-5评分相关(p=0.003)。
- 前列腺切除后海绵体肌电图分级与12个月勃起功能恢复及术后IIEF-5评分显著相关。
核心结论
- 成功建立了在机器人辅助根治性前列腺切除术中使用海绵体肌电图进行安全术中海绵体神经监测与标测的方案,其分级与勃起功能良好相关。
- 作者认为,评估保留勃起功能的临床疗效似乎值得在确证性临床试验中进一步优化和研究。
研究设计与样本
- 前瞻性I/II期可行性研究,纳入30例在高容量三级学术医院接受机器人辅助根治性前列腺切除术的前列腺癌患者。
- 在全程静脉麻醉联合控制性肌肉松弛下,于常规机器人辅助根治性前列腺切除术中评估阴部体感诱发电位、球海绵体反射、自发性海绵体肌电图、正中神经刺激诱发的海绵体肌电图及不同刺激方案下神经血管束触发的海绵体肌电图。
- 主要终点为计划手术和评估的完成率;在1年内评估不良事件及勃起和排尿功能;对海绵体肌电图进行分级并与功能结局进行相关性分析。
主要发现
- 计划手术和评估的完成率为100%;仅1例患者出现不良事件,且与研究干预无关。
- 前列腺切除前神经血管束触发的海绵体肌电图分级与基线IIEF-5评分相关:0-1级为4.6±2.7,2级为13.2±6.8,3-4级为16.6±5.9(p=0.003)。
- 前列腺切除后海绵体肌电图分级与12个月勃起功能恢复显著相关:0级为12.5%,1级为0%,2级为33.3%,3-4级为100%(p=0.005)。
- 前列腺切除后海绵体肌电图分级与所有评估时间点的术后IIEF-5评分显著相关:12个月时0-1级为2.6±2.8,2级为4.3±5.8,3-4级为15.7±11.0(p=0.003)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Potency preservation often does not meet expectation despite nerve-sparing prostatectomy. OBJECTIVE: To set the protocol for intraoperative cavernous nerve monitoring and mapping during robot-assisted radical prostatectomy (RARP), and to evaluate its safety and clinical feasibility. DESIGN, SETTING, AND PARTICIPANTS: A prospective phase I/II, feasibility study was performed. A total of 30 patients with prostate cancer who underwent RARP at a high-volume tertiary academic hospital were enrolled. SURGICAL PROCEDURE: Pudendal somatosensory evoked potential, bulbocavernosus reflex, spontaneous corpus cavernosum electromyography (CC-EMG), median nerve stimulation evoked CC-EMG, and neurovascular bundle (NVB)-triggered CC-EMG with various stimulation protocols were assessed during conventional RARP under total intravenous anesthesia with controlled muscle relaxation. MEASUREMENTS: The primary endpoint was the completion rate of planned surgery and assessment. Adverse events, and erectile and urinary functions were evaluated within 1 yr. CC-EMGs were graded and correlated with functional outcomes. RESULTS AND LIMITATIONS: The completion rate was 100%. Only one patient experienced adverse events, which were not related to study intervention. Grades of CC-EMGs including NVB-triggered CC-EMG before prostate removal were associated with baseline five-item International Index of Erectile Function (IIEF-5) score (grades 0-1, 4.6±2.7; grade 2, 13.2±6.8; grades 3-4, 16.6±5.9; p=0.003). Furthermore, grades of CC-EMGs including NVB-triggered CC-EMG after prostate removal were significantly associated with potency recovery (grade 0, 12.5%; grade 1, 0%; grade 2, 33.3%; grades 3-4, 100% at 12 mo; p=0.005) and postoperative IIEF-5 scores at all evaluation time points (grades 0-1, 2.6±2.8; grade 2, 4.3±5.8; grades 3-4, 15.7±11.0 at 12 mo; p=0.003). CONCLUSIONS: We successfully established the protocol for safe intraoperative cavernous nerve monitoring and mapping using CC-EMG during RARP. Its grades were well correlated with erectile function. PATIENT SUMMARY: In this first-in-human feasibility study, we successfully established the protocol for safe intraoperative cavernous nerve monitoring and mapping method during robot-assisted radical prostatectomy. The results were significantly associated with erectile function. Evaluation of clinical efficacy to preserve potency seems worthy of further optimization and investigation in confirmatory clinical trials.
引用
- Song WH, Park JH, Tae BS, et al. Establishment of Novel Intraoperative Monitoring and Mapping Method for the Cavernous Nerve During Robot-assisted Radical Prostatectomy: Results of the Phase I/II, First-in-human, Feasibility Study. Eur Urol. 2019. PMID: 31103393. doi:10.1016/j.eururo.2019.04.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。